We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Aiming to hang on to some of the highly profitable Allegra market, sanofi-aventis is launching an authorized generic of the allergy drug through Prasco Laboratories.
Rivals Barr Pharmaceuticals and Teva Pharmaceutical have partnered to market a generic version of sanofi-aventis’ blockbuster allergy drug Allegra, the companies said Sept. 6. Barr received final FDA approval to market its version of the drug last week.
NexMed has licensed its nail fungus treatment to Novartis Pharmaceuticals, maker of nail antifungal Lamisil, which could allow Novartis to create a topical version of Lamisil as effective as the oral drug but with fewer side effects.
Iceland-based generic drugmaker Actavis has inked an agreement to purchase Higia, one of Bulgaria’s largest pharmaceutical distributors, for an undisclosed sum.
Rivals Barr Pharmaceuticals and Teva Pharmaceutical have partnered to market a generic version of sanofi-aventis’ blockbuster allergy drug Allegra, the companies said Sept. 6. Barr received final FDA approval to market its version of the drug last week.
Looking to make another big splash on the acquisitions front, Novartis has offered $4.5 billion in cash for the remaining shares of California-based vaccine maker Chiron.
The European Commission approved Johnson & Johnson’s (J&J’s) planned $25.4 billion takeover of medical devicemaker Guidant Aug. 25, subject to a number of conditions regarding fair competition practices.
Labopharm has entered into a U.S. distribution and licensing agreement with Purdue Pharma for a once-daily version of Ortho-McNeil Pharmaceutical’s analgesic drug tramadol. Labopharm said it plans to submit its new drug application (NDA) to the FDA later this year.
Quest Diagnostics has agreed to a deal in which it will acquire LabOne, a Lenexa, Kan.-based provider of health-screening and risk-assessment services to life insurance companies, the company said early last week.